Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy
Clinical trial NCT05180006 · TERMINATED
Trial details
- NCT number
- NCT05180006
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-24
- Primary completion
- 2024-12-17
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.